Association of Oral Tobacco-Free Nicotine Delivery Product with Acute Renal Tubular Necrosis
- PMID: 39597031
- PMCID: PMC11596808
- DOI: 10.3390/medicina60111846
Association of Oral Tobacco-Free Nicotine Delivery Product with Acute Renal Tubular Necrosis
Abstract
Usage of novel non-tobacco oral nicotine delivery products (ONDPs) has been increasing among adolescents in the United States. It is presumed that they are less toxic than their tobacco-containing counterparts, but that has not been examined in controlled studies. Most of the studies have focused on non-renal manifestations of tobacco consumption via different means. The renal manifestations of non-tobacco ONDPs are not very well known, especially in immunocompromised patients. A 19-year-old male transplant recipient presented with flank pain and a few days' history of intake of ZYNR pouches. Immunosuppression was with tacrolimus, mycophenolate, and steroids. Baseline serum creatinine was 1.1-1.3 mg/dL. Laboratory evaluation showed elevated C-reactive protein, increased serum creatinine and blood urea nitrogen, leukocytosis, neutrophilia, and increased lactate dehydrogenase (LDH). Infectious disease work-up was negative. A kidney transplant biopsy showed severe acute tubular injury/necrosis (ATN) without evidence of rejection. Donor-specific antibodies were negative. Other etiologies of hemolysis were negative. He did not require renal replacement therapy. Kidney function and LDH improved gradually. The most recent follow-up eight months after presentation showed a serum creatinine level of 2.6 mg/dL with stable electrolytes, with eGFR of 35 mL/min/1.73 m2. Here, we describe a 19-year-old adolescent with a kidney transplant who sustained ATN leading to advanced chronic disease apparently following the usage of non-tobacco ONDP. Further larger studies are needed to study ATN as a possible renal manifestation of these next-generation products to raise awareness among the public.
Keywords: acute tubular necrosis; adolescents; kidney transplant; oral nicotine delivery product.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures
References
-
- Park-Lee E., Jamal A., Cowan H., Sawdey M.D., Cooper M.R., Birdsey J., West A., Cullen K.A. Notes from the field: E-Cigarette and nicotine pouch use among middle and high school students—United States, 2024. MMWR Morb. Mortal. Wkly. Rep. 2024;73:774–778. doi: 10.15585/mmwr.mm7335a3. - DOI - PMC - PubMed
-
- Back S., Masser A.E., Rutqvist L.E., Lindholm J. Harmful and potentially harmful constituents (HPHCs) in two novel nicotine pouch products in comparison with regular smokeless tobacco products and pharmaceutical nicotine replacement therapy products (NRTs) BMC Chem. 2023;17:9. doi: 10.1186/s13065-023-00918-1. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous
